Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs Innate Pharma S.A. Sponsored ADR (IPHA)

AN2 Therapeutics, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. AN2 Therapeutics, Inc. and Innate Pharma S.A. Sponsored ADR are of similar size ($160.4M and $159.2M). AN2 Therapeutics, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Innate Pharma S.A. Sponsored ADR leads on 5 and AN2 Therapeutics, Inc. on 4.

Valuation

Metric ANTX IPHA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 2.34 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 0.12 8.98
Earnings yield (26.95%) (83.33%) (34.89%)
Free cash flow yield (17.27%) 0.00% (24.52%)

Profitability

Metric ANTX IPHA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) 0.00% (50.12%)
Return on assets (46.06%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX IPHA Biotechnology median
Revenue growth (TTM) — (4.17%) 6.26%
EPS growth (last fiscal year) 32.56% 6.06% 29.88%
Revenue growth, 5-year CAGR — (33.86%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANTX IPHA Biotechnology median
Debt to equity 0.00 (0.50) 0.00
Current ratio 14.32 0.60 4.89
Net debt to EBITDA 1.48 0.22 1.01

Dividend

Metric ANTX IPHA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANTX IPHA Biotechnology median
Market cap 160.38m 159.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack